Slingshot Biosciences is working on an overlooked but ubiquitous problem in healthcare that has a tremendous impact on a variety of patient outcomes: the lack of consistent reference material for cell-based assays. The company’s cell mimics represent a new way to use control material in the workflow, whether for instrument manufacturing, assay setup, and validation or as a manufacturing QC control. Synthetic cell mimics provide a new opportunity for precise, biologically-relevant, and cost-effective controls to aid many healthcare and research efforts globally. Learn more at slingshotbio.com